Selecting chemotherapy schedules for adjuvant treatment of early stage breast cancer, what is the rationale behind?
Breast cancer is one of the most prevalent cancers that oncologists are faced with in their clinics. The varieties of clinical features of the disease result to very different scenarios in the processes of treatment decision making. While classic factors of stage, grade, age and hormone receptor sta...
Main Authors: | Roham Salek, Narges Bayat Mokhtari, Soudabeh Shahidsales |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2015-07-01
|
Series: | Reviews in Clinical Medicine |
Subjects: | |
Online Access: | https://rcm.mums.ac.ir/article_4340_0ef7790a2fa010c913be579434a91ec6.pdf |
Similar Items
-
Adjuvant Chemotherapy of Early Stage Breast Cancer in Community-based Cancer Treatment Fields: CMF Compared with Anthracycline/Taxane-based Regimens
by: Narges Bayat Mokhtari, et al.
Published: (2017-04-01) -
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
by: Bonomi Maria, et al.
Published: (2011-12-01) -
Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients
by: Sheng‐Kai Liang, et al.
Published: (2023-09-01) -
Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial
by: Yoshimura Kenichi, et al.
Published: (2013-01-01) -
Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
by: Xi-Lin Yang, et al.
Published: (2022-10-01)